Literature DB >> 25316857

Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study series.

Li Li1, Olga Ivanova2, Nadia Driss3, Marysia Tiongco-Recto4, Rajiva da Silva5, Shohreh Shahmahmoodi6, Hossain M S Sazzad7, Ondrej Mach8, Anna-Lea Kahn8, Roland W Sutter8.   

Abstract

BACKGROUND: Persons with primary immune deficiency disorders (PID), especially those disorders affecting the B-cell system, are at substantially increased risk of paralytic poliomyelitis and can excrete poliovirus chronically. However, the risk of prolonged or chronic excretion is not well characterized in developing countries. We present a summary of a country study series on poliovirus excretion among PID cases.
METHODS: Cases with PID from participating institutions were enrolled during the first year and after obtaining informed consent were tested for polioviruses in stool samples. Those cases excreting poliovirus were followed on a monthly basis during the second year until 2 negative stool samples were obtained.
RESULTS: A total of 562 cases were enrolled in Bangladesh, China, Iran, Philippines, Russia, Sri Lanka, and Tunisia during 2008-2013. Of these, 17 (3%) shed poliovirus, including 2 cases with immunodeficient vaccine-derived poliovirus. Poliovirus was detected in a single sample from 5/17 (29%) cases. One case excreted for more than 6 months. None of the cases developed paralysis during the study period.
CONCLUSIONS: Chronic polioviruses excretion remains a rare event even among individuals with PID. Nevertheless, because these individuals were not paralyzed they would have been missed by current surveillance; therefore, surveillance for polioviruses among PID should be established.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  OPV; poliovirus excretion; primary immune deficiency; vaccine-derived polioviruses

Mesh:

Year:  2014        PMID: 25316857     DOI: 10.1093/infdis/jiu065

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

Review 1.  Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.

Authors:  Laura Pöyhönen; Jacinta Bustamante; Jean-Laurent Casanova; Emmanuelle Jouanguy; Qian Zhang
Journal:  J Clin Immunol       Date:  2019-05-23       Impact factor: 8.317

Review 2.  Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication.

Authors:  Jean Guo; Sara Bolivar-Wagers; Nivedita Srinivas; Marisa Holubar; Yvonne Maldonado
Journal:  Vaccine       Date:  2015-01-16       Impact factor: 3.641

Review 3.  Neurologic Safety Monitoring of COVID-19 Vaccines: Lessons From the Past to Inform the Present.

Authors:  Kiran Teresa Thakur; Samantha Epstein; Amanda Bilski; Alanna Balbi; Amelia K Boehme; Thomas H Brannagan; Sarah Flanagan Wesley; Claire S Riley
Journal:  Neurology       Date:  2021-09-02       Impact factor: 9.910

4.  Co-appearance of OPV and BCG vaccine-derived complications in two infants with severe combined immunodeficiency.

Authors:  Sophia Heiman; Merav Weil; Lester M Shulman; Amos J Simon; Atar Lev; Raz Somech; Tali Stauber
Journal:  Immunol Res       Date:  2018-06       Impact factor: 4.505

5.  Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy.

Authors:  R J Duintjer Tebbens; K M Thompson
Journal:  Epidemiol Infect       Date:  2016-10-20       Impact factor: 2.451

6.  Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.

Authors:  Mohammadreza Shaghaghi; Shohreh Shahmahmoodi; Hassan Abolhassani; Saeed Soleyman-Jahi; Leila Parvaneh; Sussan Mahmoudi; Zahra Chavoshzadeh; Reza Yazdani; Seyed Mohsen Zahraei; Mohsen Ebrahimi; Mohammad H Eslamian; Hamideh Tabatabaie; Maryam Yousefi; Yaghoob M Kandelousi; Aliasghar Oujaghlou; Nima Rezaei; Asghar Aghamohammadi
Journal:  Emerg Infect Dis       Date:  2016-10       Impact factor: 6.883

7.  Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Kimberly M Thompson
Journal:  BMC Infect Dis       Date:  2015-09-17       Impact factor: 3.090

8.  Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015.

Authors:  Ousmane M Diop; Cara C Burns; Roland W Sutter; Steven G Wassilak; Olen M Kew
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-06-19       Impact factor: 17.586

9.  Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.

Authors:  Thomas Foiadelli; Salvatore Savasta; Andrea Battistone; Majlinda Kota; Carolina Passera; Stefano Fiore; Silvia Bino; Concetta Amato; Alessandro Lozza; Gian Luigi Marseglia; Lucia Fiore
Journal:  BMC Infect Dis       Date:  2016-06-10       Impact factor: 3.090

10.  Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013.

Authors:  Ousmane M Diop; Cara C Burns; Steven G Wassilak; Olen M Kew
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-03-21       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.